{name}
{subtitle}
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment
city
~56 mi. (Ashkelon, Israel, +142 more cities)
facility
Barzilai Medical Center
biomarker
del(11)(q10), +27 more biomarkers
drug
imetelstat, +1 more drug
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
city
~88 mi. (Tel Aviv, Israel, +201 more cities)
facility
Tel Aviv Sourasky Medical Center /ID# 221896
drug
azacitidine, +1 more drug
A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)
city
~88 mi. (Ramat Gan, Israel, +127 more cities)
facility
The Chaim Sheba Medical Center /ID# 214305
drug
azacitidine, +2 more drugs
A Study of Oral Venetoclax Tablets and Oral Azacitidine Versus Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy
city
~88 mi. (Tel Aviv, Israel, +197 more cities)
facility
Tel Aviv Sourasky Medical Center /ID# 239698
biomarker
BCR-ABL1 Fusion, +47 more biomarkers
drug
azacitidine, +1 more drug
A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
city
~88 mi. (Tel Aviv, Israel, +156 more cities)
facility
Tel Aviv Sourasky Medical Center /ID# 169437
biomarker
IGH-CCND1 Fusion, +1 more biomarker
drug
dexamethasone, +1 more drug
drug type
chemotherapy, +1 more type
Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis
city
~88 mi. (Ramat Gan, Israel, +165 more cities)
facility
The Chaim Sheba Medical Center /ID# 219137
biomarker
del(11)(q10), +27 more biomarkers
drug
navitoclax, +1 more drug
Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple Myeloma
city
~88 mi. (Ramat Gan, Israel, +54 more cities)
facility
The Chaim Sheba Medical Center /ID# 229483
drug
carfilzomib, +4 more drugs
drug type
chemotherapy, +3 more types